Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers ...
Oct 21, 2020
0
19